Community/Retail

Simulation exercises can positively alter pharmacy students' attitudes toward poverty.

Patient access to biosimilars will hinge on critical policy decisions around extrapolation and biosimilar label content, asserts the Biosimilars Council, a division of the Generic Pharmaceutical Association in comments to the Food and Drug Administration Arthritis Advisory Committee.

The National Community Pharmacists Association today announced its 2016 lineup of one-day seminars to help community pharmacy owners and front-end staff hone their merchandising and marketing skills, as well as a new sponsorship by Good Neighbor Pharmacy and Amerisource Bergen Drug Corporation to continue the Front-End Profit Building Seminars program.

The Pharmacy Quality Alliance has announced an expansion of its team by bringing on board two new staff and promoting an individual from the existing PQA team into a new position.

The PQA has announced that the PQA-endorsed measure, Use of Opioids at High Dosage in Persons Without Cancer, has been included in the Medicaid Adult Core Set of Measures for federal fiscal year 2016.

The FDA has granted approval to Shire's lifitegrast ophthalmic 5% solution (Xiidra), a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adults.

Dual-degree programs allow pharmacy students to diversify their training and pursue certain career paths more easily than they would with a PharmD alone.

If your patients went elsewhere with their scripts, you may not be able to regain that lost business, but you can recapture their loyalty by offering new solutions to their aches, pains, and other maladies.

The FDA recently approved a device implanted in the cornea of one eye to improve near vision in certain patients with presbyopia.

The pitfalls of a pharmacist surplus have been clearly outlined, but several types of individuals and institutions may benefit from having more pharmacists in the marketplace.

The FDA has approved Insys Therapeutics Inc's oral solution, Syndros, which is a liquid formulation of the pharmaceutical cannabinoid dronabinol.

It's Friday afternoon and your hospital receives an e-mail from the Health Resources and Services Administration, notifying you that your hospital has been selected for a 340B program audit. Are you ready?

3M Drug Delivery Systems will be working to introduce its Intelligent Inhaler to the market by developing a partnership with pharmaceutical companies.

Pillo is a slightly creepy-looking form of artificial intelligence that uses facial recognition to dispense medication and apparently also automatically reorder medicine before it runs out.

Completing a best possible medication history is a crucial first step in the medication reconciliation process.

Tina Miller, MS, RD, has been named president of the Michigan Academy of Nutrition and Dietetics.

Starting a new job can be exciting, but the first days or weeks can feel overwhelming.

Depression affects 10% to 40% of patients with heart failure, depending on disease severity.

Dream Body Weight Loss is voluntarily recalling several of its products due to undeclared sibutramine.

Results of 2016 Kantar Media Readership Study Demonstrate Pharmacy Times' Continuous Leadership Among Retail Pharmacists

Beginning July 18, pharmacies will be required to abide by rules that regulate discriminatory behavior and practices

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The US Department of Health and Human Services has officially increased the limit on the number of patients for whom providers can prescribe buprenorphine from 100 to 275.

Don't miss out on this week's must-read pharmacy stories!

Learn about the new drugs and expanded indications approved by the FDA in June 2016.